Analysed LONGEVERON INC-A (LGVN:NASDAQ) News Sources
Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in Patients with Alzheimer’s Disease
13-07-2026
yahoo.com
Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026
03-08-2026
yahoo.com
What is the current price of LONGEVERON INC-A (LGVN:NASDAQ)?
The current price of LONGEVERON INC-A (LGVN:NASDAQ) is $6.8.
LONGEVERON INC-A (LGVN:NASDAQ) absolute price change since previous trading day?
The absolute price change of LONGEVERON INC-A (LGVN:NASDAQ) since the previous trading day is $-0.233.
LONGEVERON INC-A (LGVN:NASDAQ) percentage price change since previous trading day?
The percentage price change of LONGEVERON INC-A (LGVN:NASDAQ) since the previous trading day is -3.313%.
What is the most recent average sentiment score for LONGEVERON INC-A (LGVN:NASDAQ)?
The most recent average sentiment score for LONGEVERON INC-A (LGVN:NASDAQ) is 76 out of 100.
What is the most recent average sentiment for LONGEVERON INC-A (LGVN:NASDAQ)?
The most recent sentiment for LONGEVERON INC-A (LGVN:NASDAQ) is .
SEC-8K** Filing Available For LONGEVERON INC-A (LGVN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.